Low-molecular-weight heparins: Review of their role for unstable angina/non- Q-wave MI

Low-molecular-weight heparins: Review of their role for unstable angina/non- Q-wave MI

The advantages of low-molecular-weight heparins generally and the cumulative evidence for an efficacy benefit with enoxaparin argue for strong consideration of enoxaparin as an alternative to unfractionated heparin in the acute phase of unstable angina and non-Q-wave myocardial infarction.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Formulary (Cleveland, Ohio) Ohio), 2000-12, Vol.35 (12), p.970
Hauptverfasser: Reinhard, Felicia, Ravnan, Marcus C, Matalka, Mazen S
Format: Artikel
Sprache:eng
Schlagworte:
Angina pectoris
Anticoagulants
Aspirin
Atherosclerosis
Bioavailability
Blood platelets
Cardiovascular disease
Coronary vessels
Dosage and administration
Drug therapy
Endothelium
Evaluation
Heart attack
Heart attacks
Heparin
Ischemia
Molecular weight
Pharmacology
Plasma
Product/service Evaluations
Proteins
Smooth muscle
Thrombocytopenia
Unstable angina
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The advantages of low-molecular-weight heparins generally and the cumulative evidence for an efficacy benefit with enoxaparin argue for strong consideration of enoxaparin as an alternative to unfractionated heparin in the acute phase of unstable angina and non-Q-wave myocardial infarction.
ISSN:1082-801X
1938-1166